Open AccessClinical Outcomes of Very Elderly Patients With Atrial Fibrillation Receiving On‐label Doses of Apixaban: J‐ELD AF Registry Subanalysis
Author(s) -
Masato Okada,
Koichi Inoue,
Nobuaki Tanaka,
Yasushi Sakata,
Masaharu Akao,
Takeshi Yamashita,
Shinya Suzuki,
Ken Okumura,
JELD AF investigators
Publication year - 2021
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.121.021224
Subject(s) - medicine , atrial fibrillation , apixaban , hazard ratio , stroke (engine) , prospective cohort study , proportional hazards model , incidence (geometry) , antithrombotic , cohort , cohort study , cardiology , rivaroxaban , warfarin , confidence interval , engineering , mechanical engineering , optics , physics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom